RNA methylation and breast cancer: insights into m6A, m7G and m5C

Yuhan Dai1, Shuhan Zhao1, Huilin Chen1

  • 1Department of breast surgery, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China.

Molecular Biology Reports
|November 29, 2024
PubMed

Insights

RNA modifications, especially methylation (m6A, m7G, m5C), are key in breast cancer progression and resistance. Targeting these RNA methylation regulators offers new avenues for precision medicine and improved patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Breast cancer exhibits molecular diversity, posing challenges in treatment due to heterogeneity and resistance.
  • RNA modifications are increasingly recognized as critical regulators in cancer biology.
  • Methylation, a key RNA modification, influences cancer progression, metastasis, and treatment resistance.

Purpose of the Study:

  • To review the roles of key RNA methylations in breast cancer.
  • To examine the functions of RNA methylation "writers," "readers," and "erasers."
  • To explore the therapeutic potential of targeting RNA methylation in breast cancer.

Main Methods:

  • Literature review focusing on RNA methylation in breast cancer.
  • Analysis of the roles of specific RNA methylation types (m6A, m7G, m5C, m1A, m3C) and their associated proteins.
  • Exploration of the interplay between RNA methylation and non-coding RNAs.

Main Results:

  • N6-methyladenosine (m6A) modifications, regulated by METTL3, METTL14, FTO, and ALKBH5, impact tumor behavior, stem cell phenotypes, chemoresistance, and immune evasion.
  • N7-methylguanosine (m7G) modifications influence mRNA stability and translation, presenting a therapeutic target.
  • Other methylations (m5C, m1A, m3C) and their interplay with non-coding RNAs are implicated in breast cancer tumorigenesis and prognosis.

Conclusions:

  • RNA methylations are crucial in breast cancer development and progression.
  • Dysregulation of RNA methylation pathways contributes to treatment resistance and immune evasion.
  • Targeting RNA methylation pathways presents a promising strategy for novel breast cancer therapies and precision medicine.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
136
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.3K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K